Medtronic (MDT) Fundamental Analysis: Revenue, Earnings & Valuation

8.82 / 10

Outperform

Fundamental analysis scores 8.82 (Outperform). Asset‑MV, ROA, cash‑MV and profit margins rank in top quartiles, delivering strong quality scores. Profit‑MV is the sole weak factor with negative weight, slightly dragging the composite rating, but overall fundamentals remain robust.

Analysis Checks(9/10)

ROA (%)

Value5.16

Score3/3

Weight8.85%

1M Return0.90%

Net cash flow from operating activities / Operating revenue (%)

Value21.00

Score3/3

Weight18.36%

1M Return1.78%

Profit-MV

Value-0.39

Score1/3

Weight-41.77%

1M Return-5.65%

Net profit margin (%)

Value13.99

Score3/3

Weight8.13%

1M Return0.82%

Total profit / EBIT (%)

Value88.53

Score3/3

Weight15.32%

1M Return1.54%

Net cash flow from operating activities / Total liabilities (%)

Value0.16

Score2/3

Weight7.50%

1M Return0.75%

Annualized net profit margin on total assets (%)

Value5.16

Score3/3

Weight8.85%

1M Return0.90%

Asset-MV

Value0.25

Score3/3

Weight33.24%

1M Return3.20%

Cash-MV

Value0.27

Score3/3

Weight30.19%

1M Return3.03%

Net profit / Total profit (%)

Value83.35

Score3/3

Weight11.34%

1M Return1.16%

Is MDT undervalued or overvalued?

MDT scores 8.82/10 on fundamentals and holds a Discounted valuation at present. Backed by its 7.30% ROE, 13.07% net margin, 24.10 P/E ratio, 2.26 P/B ratio, and 9.09% earnings growth, these metrics solidify its Outperform investment rating.